Task force 6. Cost effectiveness of assessment and management of risk factors

This publication has 34 references indexed in Scilit:

• The Cost-effectiveness of HMG-CoA Reductase Inhibitors to Prevent Coronary Heart Disease
  Published by American Medical Association (AMA) ,1995
• Cost-effectiveness analysis in heart disease Part I: General principles
  Progress in Cardiovascular Diseases, 1994
• Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications
  The American Journal of Cardiology, 1993
• Cost and health implications of cholesterol lowering.
  Circulation, 1992
• An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
  The American Journal of Cardiology, 1991
• Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
  Published by American Medical Association (AMA) ,1991
• A Clinician's Guide to Cost-Effectiveness Analysis
  Annals of Internal Medicine, 1990
• Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease
  New England Journal of Medicine, 1990
• Estimating the benefits of cholesterol lowering: Are risk factors for coronary heart disease multiplicative?
  Journal of Clinical Epidemiology, 1990
• Cutting Into Cholesterol
  JAMA, 1988